Clinical Trials on Metastatic Prostate Cancer in Canada
Total 4123 results
-
CHU de Quebec-Universite LavalActive, not recruitingProstate CancerCanada
-
St. Mary's Research Center, CanadaSunnybrook Health Sciences Centre; University of British Columbia; McGill University and other collaboratorsNot yet recruitingAnxiety | Cancer of the ProstateCanada
-
Profound Medical Inc.RecruitingProstate Cancer | Prostate AdenocarcinomaUnited States, Canada, Finland
-
Eli Lilly and CompanyCompletedMetastatic Cancer | Advanced CancerUnited States, Canada
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Nonmetastatic Castration-Resistant Prostate CancerHong Kong, Canada, China, Germany, Spain, Netherlands, United Kingdom, Korea, Republic of, Taiwan, Australia, Denmark, France, United States, Singapore, Poland, Malaysia, Turkey, Belgium, Argentina, Thailand, Slovakia, Brazil, Finland, Ita... and more
-
CHU de Quebec-Universite LavalCentre de recherche du Centre hospitalier universitaire de Sherbrooke; McGill... and other collaboratorsActive, not recruitingProstate Cancer | EpidemiologyCanada
-
Saskatchewan Health Authority - Regina AreaCompleted
-
Ontario Clinical Oncology Group (OCOG)AstraZenecaCompleted
-
EDAP TMS S.A.UnknownProstate CancerUnited States, Canada
-
CMX ResearchFerring PharmaceuticalsCompleted
-
Steba Biotech S.A.CompletedEfficacy,Safety and Quality of Life After TOOKAD® Soluble VTP for Localized Prostate Cancer (PCM304)Prostate CancerMexico, Panama, Peru
-
CMX ResearchSanofiCompleted
-
Sir Mortimer B. Davis - Jewish General HospitalAbbottRecruitingAdjuvant Androgen Suppression Plus Radiation Therapy for High-Risk Localized Adenocarcinoma ProstateAdenocarcinoma of the ProstateCanada
-
NCIC Clinical Trials GroupCompletedProstate Cancer | Precancerous/Nonmalignant ConditionCanada
-
PfizerAstellas Pharma Inc; Medivation LLC, a wholly owned subsidiary of Pfizer Inc.Active, not recruitingProstate Cancer | Cancer of the Prostate | Hormone Sensitive Prostate CancerCanada, United States, France, Spain, Australia, Sweden, Taiwan, Finland, Korea, Republic of, Netherlands, United Kingdom, Denmark, Brazil, Slovakia, Austria, Italy, Poland
-
Royal Victoria Hospital, CanadaMcGill UniversityCompletedBenign Prostate HyperplasiaCanada
-
University of AlbertaRecruitingProstate Cancer | Metabolic Disease | IncontinenceCanada
-
Dr. D. Robert SiemensCompleted
-
Taha UçarUnknownPain | Lower Urinary Tract Symptoms | Bladder Cancer | Benign Prostate Hyperplasia | HematuriaTurkey
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
Southwest Oncology GroupNational Cancer Institute (NCI); European Organisation for Research and Treatment... and other collaboratorsCompleted
-
GlaxoSmithKlineCompletedNeoplasms, ProstateUnited States, Australia, France, Germany, Spain, Bulgaria, Estonia, Italy, Poland, Netherlands, Belgium, United Kingdom, Canada, Denmark, Ukraine, Finland, Latvia, Russian Federation, Greece, Slovenia, Brazil, Mexico, Slovakia, Japan, Puerto... and more
-
University Health Network, TorontoUniversity of British Columbia; University of Toronto; Dalhousie University; Canadian... and other collaboratorsActive, not recruiting
-
ExelixisCompletedPain | Prostatic Neoplasms | Prostate Cancer | Castration Resistant Prostate CancerBelgium, France, Italy, Canada, United States, Germany, United Kingdom, Australia, Netherlands, Spain, Austria, Ireland, Puerto Rico, Sweden
-
Progenics Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
St. Joseph's Healthcare HamiltonOntario Ministry of Health and Long Term CareCompletedBenign Prostatic HyperplasiaCanada
-
Canadian Cancer Trials GroupPfizerActive, not recruiting
-
University of British ColumbiaUniversity Health Network, Toronto; Janssen Inc.RecruitingGenomic Biomarker-Selected Umbrella Neoadjuvant Study for High Risk Localized Prostate Cancer (GUNS)Prostate CancerCanada, United States
-
Sunnybrook Health Sciences CentreTerminated
-
University College, LondonRecruitingProstate CancerUnited States, Canada, Spain, Finland, Argentina, Australia, Belgium, Brazil, Denmark, France, Germany, Italy, Netherlands, Singapore, United Kingdom
-
PRAECIS Pharmaceuticals Inc.CompletedProstate CancerUnited States
-
Nova Scotia Health AuthorityRecruiting
-
University Health Network, TorontoCanadian Institutes of Health Research (CIHR)CompletedSexual Dysfunction | Prostate Cancer | Erectile Dysfunction Following Radical ProstatectomyCanada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada, Czech Republic, Germany, Hungary, Mexico, Netherlands, Puerto Rico, Romania, Russian Federation, Ukraine, United Kingdom
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Czech Republic, Hungary, Romania, Canada
-
NCIC Clinical Trials GroupTerminated
-
Canadian Cancer Trials GroupEndocyte; Prostate Cancer CanadaActive, not recruiting
-
LTN PHARMACEUTICALS, INC.TerminatedProstate CancerUnited States, Canada
-
AbbVieJSS Medical Research; CMX Research Inc.; Canadian Urology Research ConsortiumCompleted
-
Millennium Pharmaceuticals, Inc.CompletedProstate CancerUnited States, Canada
-
Astex Pharmaceuticals, Inc.CompletedProstate CancerUnited States, United Kingdom, Spain, Canada
-
Canadian Cancer Trials GroupCompleted
-
Alethia BiotherapeuticsRecruitingMetastatic Colorectal CancerCanada
-
Alliance for Clinical Trials in OncologyNational Cancer Institute (NCI)CompletedProstate CancerUnited States, Canada
-
Ferring PharmaceuticalsCompletedProstate CancerUnited States, Canada
-
CHU de Quebec-Universite LavalRecruiting
-
IpsenCompleted
-
British Columbia Cancer AgencyActive, not recruiting